The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer
Stefania Gori(Ospedale Sacro Cuore Don Calabria), Alessandro Inno(Ospedale Sacro Cuore Don Calabria), Fabio Puglisi(University of Udine), Patrizia Vici(Istituti di Ricovero e Cura a Carattere Scientifico), Filippo Alongi(Ospedale Sacro Cuore Don Calabria), Elisabetta Cretella(Ospedale di Bolzano), Gianluigi Lunardi(Ospedale Sacro Cuore Don Calabria), Nicla La Verde(ASST Fatebenefratelli Sacco), Lucio Laudadio(Ospedale "Floraspe Renzetti"), Emiliana Tarenzi(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Alessandra Fabi(Agostino Gemelli University Polyclinic), S. Moroso(Ospedale Santa Maria della Misericordia di Udine), Sandro Barni, Daniele Galanti(Ospedale Sacro Cuore Don Calabria), Monica Turazza(Ospedale Sacro Cuore Don Calabria), Antonio Frassoldati(Italian Oncology Group of Clinical Research), Luigi Cavanna(University of Pavia), V. Leonardi(University of Palermo), Antonio Russo(University of Palermo), Fabiana Marchetti(Ospedale Sacro Cuore Don Calabria), Matteo Valerio(Ospedale Sacro Cuore Don Calabria), Jennifer Foglietta, Ornella Garrone(Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo)
Cited by 15
Related Papers
Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
|Journal of Clinical Oncology|2010|887
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
|New England Journal of Medicine|2014|751
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
|New England Journal of Medicine|2018|684
Distance as a Barrier to Cancer Diagnosis and Treatment: Review of the Literature
|The Oncologist|2015|531